EUVIMEDEUVIMED entdecken
Open Access

Association of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis

Hibiki Mima iD, Fusako Sera iD, Tomohito Ohtani iD, Yasuhiro Akazawa iD, Shozo Konishi iD, Takafumi Oka iD, Yasushi Sakata iD

Journal of the American Heart Association · 01.09.2026 · 15 (17)

DOI: 10.1161/jaha.126.050214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 01.09.2026. Verfasst von Hibiki Mima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine The University of Osaka Graduate School of Medicine Osaka Japan. Hauptthemen laut MEDLINE: Technetium Tc 99m Sestamibi, Exercise Tolerance, Cardiomyopathies, Myocardial Perfusion Imaging. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In nonischemic cardiomyopathy, the clinical relevance of decreased resting myocardial technetium‐99m sestamibi ( 99m Tc‐MIBI) uptake regarding exercise capacity and clinical outcomes remains incompletely understood. We investigated whether decreased 99m Tc‐MIBI uptake is associated with impaired exercise capacity and adverse clinical outcomes in nonischemic cardiomyopathy.

Methods

We retrospectively analyzed 182 patients (mean age 51.4±14.0 years; 27% female) with nonischemic cardiomyopathy and left ventricular ejection fraction

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technetium Tc 99m SestamibiExercise ToleranceCardiomyopathiesMyocardial Perfusion ImagingHumansFemaleRetrospective StudiesMiddle AgedRadiopharmaceuticalsExercise TestMaleStroke VolumeVentricular Function, LeftOxygen ConsumptionAdultPrognosisHospitalizationAged

Stichwörter der Autor:innen

clinical outcomesexercise capacityheart failurenonischemic cardiomyopathytechnetium‐99m sestamibi

Substanzen

Technetium Tc 99m SestamibiRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine The University of Osaka Graduate School of Medicine Osaka Japan.

ORCID-Profile: Hibiki Mima, Fusako Sera, Tomohito Ohtani, Yasuhiro Akazawa, Shozo Konishi, Takafumi Oka, Yasushi Sakata

Zitieren

APA

Mima, H., Sera, F., Ohtani, T., Akazawa, Y., Konishi, S., Oka, T., & Sakata, Y. (2026). Association of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis. Journal of the American Heart Association, 15(17). https://doi.org/10.1161/jaha.126.050214

Vancouver

Mima H, Sera F, Ohtani T, Akazawa Y, Konishi S, Oka T, et al. Association of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis. Journal of the American Heart Association. 2026;15(17). doi:10.1161/jaha.126.050214

BibTeX
@article{Mima2026,
  author = {Mima, Hibiki and Sera, Fusako and Ohtani, Tomohito and Akazawa, Yasuhiro and Konishi, Shozo and Oka, Takafumi and Sakata, Yasushi},
  title = {Association of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {17},
  doi = {10.1161/jaha.126.050214}
}
Kostenlos starten →